$ANNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Annexon, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Annexon, Inc.. Get notifications about new insider transactions in Annexon, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | A | 21.03 | 10,000 | 210,300 | 10,000 | |
Jun 04 2021 | ANNX | Annexon, Inc. | Sun Ricky | Director | Option Exercise | A | 21.03 | 10,000 | 210,300 | 10,000 | |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Option Exercise | M | 1.41 | 500 | 705 | 52,994 | |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Option Exercise | M | 1.41 | 7,102 | 10,011 | 53,494 | |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Sell | S | 28.01 | 300 | 8,403 | 0 | 300 to 0 (-100.00 %) |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Sell | S | 28.19 | 200 | 5,638 | 300 | 500 to 300 (-40.00 %) |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Buy | M | 1.41 | 500 | 705 | 500 | 0 to 500 |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Sell | S | 28.11 | 7,102 | 199,621 | 0 | 7.1 K to 0 (-100.00 %) |
Apr 02 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Buy | M | 1.41 | 7,102 | 10,011 | 7,102 | 0 to 7.1 K |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Option Exercise | M | 5.11 | 1,175 | 6,004 | 69,129 | |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Option Exercise | M | 1.41 | 15,000 | 21,144 | 40,615 | |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Sell | S | 29.96 | 237 | 7,101 | 0 | 237 to 0 (-100.00 %) |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Sell | S | 29.21 | 5,680 | 165,914 | 237 | 5.9 K to 237 (-95.99 %) |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Sell | S | 28.54 | 10,258 | 292,755 | 5,917 | 16.2 K to 5.9 K (-63.42 %) |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Buy | M | 5.11 | 1,175 | 6,004 | 16,175 | 15 K to 16.2 K (+7.83 %) |
Mar 29 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Buy | M | 1.41 | 15,000 | 21,144 | 15,000 | 0 to 15 K |
Mar 26 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Option Exercise | M | 7.49 | 3,995 | 29,917 | 182,956 | |
Mar 26 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Option Exercise | M | 7.49 | 3,995 | 29,917 | 182,956 | |
Mar 26 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Sell | S | 30.17 | 3,995 | 120,512 | 0 | 4 K to 0 (-100.00 %) |
Mar 26 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Sell | S | 30.17 | 3,995 | 120,512 | 0 | 4 K to 0 (-100.00 %) |
Mar 26 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Buy | M | 7.49 | 3,995 | 29,917 | 3,995 | 0 to 4 K |
Mar 26 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Buy | M | 7.49 | 3,995 | 29,917 | 3,995 | 0 to 4 K |
Mar 25 2021 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Option Exercise | M | 7.49 | 5,000 | 37,443 | 150,793 | |
Mar 25 2021 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Sell | S | 29.16 | 1,800 | 52,493 | 2,000 | 3.8 K to 2 K (-47.37 %) |
Mar 25 2021 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Sell | S | 28.43 | 1,800 | 51,175 | 3,800 | 5.6 K to 3.8 K (-32.14 %) |
Mar 25 2021 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Sell | S | 27.51 | 1,400 | 38,509 | 5,600 | 7 K to 5.6 K (-20.00 %) |
Mar 25 2021 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Buy | M | 7.49 | 5,000 | 37,443 | 7,000 | 2 K to 7 K (+250.00 %) |
Mar 01 2021 | ANNX | Annexon, Inc. | Keswani Sanjay | EVP & Chief Medical ... | Option Exercise | A | 30.07 | 115,000 | 3,458,050 | 115,000 | |
Mar 01 2021 | ANNX | Annexon, Inc. | Yednock Ted | EVP & Chief Scienti ... | Option Exercise | A | 30.07 | 115,000 | 3,458,050 | 115,000 | |
Mar 01 2021 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Option Exercise | A | 30.07 | 115,000 | 3,458,050 | 115,000 | |
Mar 01 2021 | ANNX | Annexon, Inc. | Overdorf Michael | EVP & Chief Busines ... | Option Exercise | A | 30.07 | 115,000 | 3,458,050 | 115,000 | |
Mar 01 2021 | ANNX | Annexon, Inc. | Love Douglas | President & CEO | Option Exercise | A | 30.07 | 325,000 | 9,772,750 | 325,000 | |
Feb 08 2021 | ANNX | Annexon, Inc. | Carson William H. | Director | Option Exercise | A | 24.34 | 20,000 | 486,800 | 20,000 | |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,109,407 | 0 | 0 | |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,148,147 | 0 | 0 | |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,370,685 | 0 | 0 | |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,666,667 | 0 | 0 | |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 17.00 | 200,000 | 3,400,000 | 2,730,635 | 2.5 M to 2.7 M (+7.90 %) |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 239,433 | 0 | 2,530,635 | 2.3 M to 2.5 M (+10.45 %) |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 697,860 | 0 | 2,291,202 | 1.6 M to 2.3 M (+43.80 %) |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 950,134 | 0 | 1,593,342 | 643.2 K to 1.6 M (+147.72 %) |
Jul 30 2020 | ANNX | Annexon, Inc. | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 643,208 | 0 | 643,208 | 0 to 643.2 K |
Jul 30 2020 | ANNX | Annexon, Inc. | Redmile Group, LLC | 10% Owner | Option Exercise | C | 0.00 | 14,062,719 | 0 | 0 | |
Jul 30 2020 | ANNX | Annexon, Inc. | Redmile Group, LLC | 10% Owner | Buy | C | 0.00 | 1,596,222 | 0 | 1,596,222 | 0 to 1.6 M |
Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 2,812,543 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 22,222,221 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 17.00 | 400,000 | 6,800,000 | 3,241,628 | 2.8 M to 3.2 M (+14.08 %) |
Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 319,243 | 0 | 2,841,628 | 2.5 M to 2.8 M (+12.66 %) |
Jul 28 2020 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,522,385 | 0 | 2,522,385 | 0 to 2.5 M |
Jul 28 2020 | ANNX | Annexon, Inc. | Lew Jennifer | EVP & Chief Financi ... | Buy | P | 17.00 | 2,000 | 34,000 | 2,000 | 0 to 2 K |
Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 2,812,543 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 5,537,036 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 4,016,573 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 3,095,238 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Buy | P | 17.00 | 200,000 | 3,400,000 | 1,954,978 | 1.8 M to 2 M (+11.40 %) |
Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Buy | C | 0.00 | 1,754,978 | 0 | 1,754,978 | 0 to 1.8 M |
Jul 28 2020 | ANNX | Annexon, Inc. | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 4,043,031 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 4,043,032 | 0 | 0 | |
Jul 28 2020 | ANNX | Annexon, Inc. | Flynn James E | 10% Owner | Buy | P | 17.00 | 350,000 | 5,950,000 | 808,914 | 458.9 K to 808.9 K (+76.27 %) |
Jul 28 2020 | ANNX | Annexon, Inc. | Flynn James E | 10% Owner | Buy | P | 17.00 | 350,000 | 5,950,000 | 808,914 | 458.9 K to 808.9 K (+76.27 %) |
Jul 28 2020 | ANNX | Annexon, Inc. | Flynn James E | 10% Owner | Buy | C | 0.00 | 458,914 | 0 | 458,914 | 0 to 458.9 K |
Jul 28 2020 | ANNX | Annexon, Inc. | Flynn James E | 10% Owner | Buy | C | 0.00 | 458,914 | 0 | 458,914 | 0 to 458.9 K |
Jul 24 2020 | ANNX | Annexon, Inc. | Overdorf Michael | EVP & Chief Busines ... | Option Exercise | A | 17.00 | 242,905 | 4,129,385 | 242,905 |
Page: 1